DIM

DIM Axes

AXIS 1:
Origin:
Causation/etiology and assessment of infectious risks

Thinking about the question and the assessment of infectious risks requires first of all documenting the multiplicity of relationships that are woven between humans, animals and their environment in diverse contexts. The different themes covered in this area will be as follows:

Knowledge of Host-Pathogen Interactions
Environmental impacts (exposome, resistance, climate change) on infections and the pathobiome
Epidemiological surveillance
Circulation of animal reservoirs
(Public) health policies facing infectious risks
Legitimacy of scientific discourse

AXIS 2:
Intervention:
proposals for operational solutions

This axis will concern the aspects of diagnosis, prevention and treatment of diseases linked to pathogens. The different themes covered in this area will be as follows:

Diagnostic strategies for infection screening (sequencing, mass spectrometry, bioinformatics tools)
Epidemiological strategies (modelling)
Treatment strategies (repositioning of molecules and search for new leads)
Prevention strategies (vaccine innovation, PreP, monoclonal Ab, etc.)
Communication strategies (dissemination of knowledge, vaccine acceptance)
Social strategies (precarious populations)

Gouvernance

Scientific Council

Ali Amara
Directeur de Recherche-Chef d'équipe « Biologie des virus émergents » à l'Institut de Recherche Saint-Louis
e-mail

Pascal Boireau
Scientific Coordinator DIM1Health Project – Anses
e-mail
+33 01 49 77 38 37

Ivo G BONECA

Françoise BOTTEREL-CHARTIER
Parasitologie, Mycologie - APHP

Maryse BRESSON

Simon CAUCHEMEZ

Mathilde DUPONT-NIVET

Jean ESTEBANEZ
Maitre de conférences en géographie, Université Paris-Est Créteil
e-mail

Evelyne JOUVIN-MARCHE
Immunologie, inflammation, infectiologie et microbiologie (I3M), INSERM

Solen KERNEIS

Nicolas LAINÉ

Louis Lambrechts
Responsable de structure • Interactions Virus-Insectes - Institut Pasteur - CNRS UMR 2000
e-mail

Sophie LE PODER

Jean-Daniel LELIEVRE
Physiopathologie du VIH, Immunologie clinique, APHP

Philippe LOISEAU
Chimiothérapie Antiparasitaire, Université Paris Sud

Coralie MARTIN
Immunologie, biologie vasculaire, parasitologie, Museum national d’histoire naturelle

Nicole PAVIO

Sabine RIFFAULT
Virologie, Immunologie Moléculaires, santé animale, INRA

Pascale SERROR

Stéphanie SIMON

Olivier Tenaillon
Directeur de Recherche Inserm-Institut Cochin UMR 1016, Université Paris Cité
e-mail

Jean-Nicolas TOURNIER

Joël VACUS

Thierry WIRTH

Board of directors

Nicolas CANIVET

Cathy Chapel

Camille Chaudonneret
Déléguée régional Paris 6 et 12, INSERM

Catherine Chaussain

Pr Christophe Degueurce
Directeur, EnvA

Christophe d’Enfert
PhD

Benoît Funalot

Laetitia HUIART

Jean-Louis Hunault
Président SIMV

Sun Jian-Sheng

Jean-Daniel LELIEVRE
Physiopathologie du VIH, Immunologie clinique, APHP

Anne-Helene Monsoro-Burq

Edna Pezard
Chargée de mission Recherche, Région IDF

Naceur Tounekti

Nathalie TOUZE

Haude Tymen

Michel Vidal

Coordination unit

Elie ABOU NAKAD
Chef de projet DIM1Health
e-mail

Jean-Daniel LELIEVRE
Physiopathologie du VIH, Immunologie clinique, APHP